Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04647656

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

Led by Assaf-Harofeh Medical Center · Updated on 2026-04-21

91

Participants Needed

1

Research Sites

239 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Post-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for months after recovering from the virus, and no treatment is known to date. The aim of this study is to compare the effect of HBOT vs. Sham on post COVID-19 syndrome

CONDITIONS

Official Title

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age above 18 years
  • Post-COVID-19 cognitive decline affecting quality of life lasting at least 3 months after confirmed infection
  • Willing and able to read, understand, and sign informed consent
Not Eligible

You will not qualify if you...

  • Unable to attend clinic visits or follow study protocol
  • History of traumatic brain injury or other non-COVID brain disorders
  • Active cancer
  • Substance use at baseline
  • Severe or unstable physical illnesses or major cognitive deficits at baseline
  • Previous hyperbaric oxygen therapy before enrollment
  • Chest conditions incompatible with pressure changes (including moderate to severe asthma)
  • Ear or sinus conditions incompatible with pressure changes
  • Unable to perform awake brain MRI
  • Active smoking

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Assaf-Harofeh medical center

Ẕerifin, Israel, 70300

Actively Recruiting

Loading map...

Research Team

S

Shani Zilberman-Itskovich, Dr.

CONTACT

S

Shai Efrati, Prof.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here